The Business Case for Health: A Life Sciences Imperative
The need for the private sector’s economic stewardship of global health is more critical than ever. As geopolitical priorities shift, the life sciences industry has the opportunity and responsibility to help drive sustainable progress, protect communities and secure a brighter economic future by making global health a strategic business priority.
Hosted by Devex in collaboration with Bristol Myers Squibb and CARE, this event will explore how global health investment can move from the periphery of corporate strategy to its core – driving innovation, economic growth and health security. The discussion will highlight why treating global health as a strategic priority, not philanthropy, is essential to both business success and global progress.
We’ll unpack how this investment advances the interests of the life sciences industry by:
- Expanding global economic opportunities through stronger local health systems
- Fostering scientific discovery with global research and data
- Reinforcing global health security
- Driving long-term revenue growth and business resilience for life sciences companies
Request your invitation to join us on May 21 for a conversation on how the life sciences industry can help drive sustainable progress, protect communities and secure long-term economic growth in the countries where they are based and where they operate by making global health a strategic business priority.
This event is part of Devex Impact House @WHA 79